Dogwood Therapeutics DWTX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's total equity?
- Dogwood Therapeutics (DWTX) reported total equity of $80.62M in Q1 2026.
- How has Dogwood Therapeutics's total equity changed year-over-year?
- Dogwood Therapeutics's total equity increased by 1037.6% year-over-year, from $7.09M to $80.62M.
- What is the long-term trend for Dogwood Therapeutics's total equity?
- Over 5 years (2020 to 2025), Dogwood Therapeutics's total equity has grown at a 20.1% compound annual growth rate (CAGR), from $29.94M to $74.9M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.